A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: lined (747)

DA_3+8

Description
Regimen Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA DA (3+8)–Cytarabine-Daunorubicin In-Patient Regimen • Acute Myeloid Leukaemia – InP-DA (3+8
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-3-8.pdf

DA_2+5

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA DA (2 + 5) – Cytarabine-Daunorubicin In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-DA (2+5
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-2-5.pdf

Cytarabine_2000_FludarabineIdarubicin_FLA-Ida

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (2000)-FLUDARABINE-IDARUBICIN (FLA-IDA) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (2000
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine-2000-FludarabineIdarubicin-FLA-Ida.pdf

Cytarabine_1000_FludarabineIdarubicin_FLA-Ida

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (1000)-FLUDARABINE-IDARUBICIN (FLA-IDA) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (1000
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine-1000-FludarabineIdarubicin-FLA-Ida.pdf

Cisplatin and Docetaxel

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CISPLATIN-DOCETAXEL Regimen Uterine-Cisplatin-Docetaxel Indication Recurrent/advanced uterine cancer Palliative intent WHO performance status 0
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Uterine-cancer/CisplatinDocetaxel.pdf

Niraparib

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCERS Regimen NIRAPARIB • Ovarian Cancer – Niraparib Indication • Niraparib is recommended as maintenance treatment in patients with relapsed, platinum
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Niraparib.pdf

Olaparib Tablets

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCERS OLAPARIB (tablets) This regimen may require funding. Regimen • Ovarian Cancer – Olaparib (tablets) Indication • Olaparib in its tablet
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Olaparib-Tablets.pdf

Carboplatin(AUC5)-Paclitaxel (21 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-PACLITAXEL 21 day Regimen • Ovary-Carboplatin (AUC5)-Paclitaxel (21 day) Indication • First line postoperative or
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Paclitaxel21day.pdf

Carboplatin(AUC5)-Paclitaxel (21 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Uterine-Carboplatin (AUC5)-Paclitaxel (21 day) Indication • Adjuvant treatment of high
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Uterine-cancer/CarboplatinAUC5-Paclitaxel21day.pdf

Epirubicin Fluorouracil Oxaliplatin (EOF)

Description
Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER EPIRUBICIN, FLUOROURACIL and OXALIPLATIN (EOF) Regimen • Gastrointestinal Cancer (upper) – Epirubicin-Fluorouracil-Oxaliplatin (EOF) Indication • First line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Epirubicin-Fluorouracil-Oxaliplatin-EOF.pdf
391 to 400 of 587
Previous … 38 39 40 41 42 … Next